What CAMBRIDGE BIOMEDICAL CAMPUS LTD does

Cambridge Biomedical Campus Ltd (CBC Ltd) is a non-profit private limited company incorporated in 2021 to represent and coordinate the organisations located on the Cambridge Biomedical Campus in Cambridge, UK. The company is a partnership with members drawn from both the public and private sectors, formed by the larger organisations on the campus, and operates under a trademark licence from the University of Cambridge. Its primary function is coordinating strategic development, community engagement, and shared services for the campus community, rather than operating as a profit-generating landlord.

The campus itself is one of Europe's largest life sciences clusters and the largest employment site in Cambridge, supporting over 22,000 jobs and contributing £4.7 billion annually to the UK economy. It co-locates world-class biomedical research, patient care, and education by housing Addenbrooke's Hospital, Royal Papworth Hospital, the University of Cambridge, the Medical Research Council, Cancer Research UK, the Milner Therapeutics Institute, the Cambridge Stem Cell Institute, and major commercial tenants including AstraZeneca, GSK, and Abcam. CBC Ltd's direct service offerings span property solutions (commercial real estate for life sciences companies), campus infrastructure (ANPR system, staff shuttle, autonomous Connector bus trial launched December 2025), community programmes (social life, public art, start-up support via IdeaSpace), careers resources, and news/events programming.

Revenue is not publicly disclosed and CBC Ltd operates as a non-profit, coordinating body funded through member contributions. Its strategic agenda, articulated in the Vision 2050 plan, centres on expanding transport connectivity (Cambridge South Train Station, capacity >1 million passengers/year, opening 2026), developing new clinical facilities (Cambridge Cancer Research Hospital, Cambridge Children's Hospital), and reinforcing the campus's value proposition around the "Power of Proximity" between academia, industry, and healthcare. Peter Denton was appointed Chair in April 2026.

Name

CAMBRIDGE BIOMEDICAL CAMPUS LTD

Legal name

Cambridge Biomedical Campus Ltd

Website

https://cambridge-biomedical.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Biomedical Campus Real Estate and Community Services

NAICS

Scientific Research and Development Services (5417)

SIC

Land Subdividers & Developers (No Cemeteries) (6552)

akta.pro primary industry

Life Sciences/Laboratory Property Management (BPAJAGAL)

Keywords

• Biomedical campus management
• Life sciences property
• Campus community services
• Research campus transport
• Healthcare real estate

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels10 records

Core offering

Cambridge Biomedical Campus Ltd coordinates the development, operation, and community life of the Cambridge Biomedical Campus, providing property solutions, campus travel and transport infrastructure, and community services to life sciences companies, NHS trusts, the University of Cambridge, and research institutes co-located on the site.

Product overview

Cambridge Biomedical Campus is a unified physical campus offering combining world-class biomedical research, patient care, and education facilities. The campus provides property solutions (commercial real estate for life sciences companies), careers and recruitment services, community and social programs, travel and transportation infrastructure, and news/events programming. Key infrastructure includes the Cambridge South Train Station, staff shuttle services, autonomous Connector bus trial, and multiple development phases (Vision 2050). The campus is home to major life sciences organizations including AstraZeneca, GSK, Abcam, and research institutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Property Solutions Property solutions offering to tenants and prospective occupiers on the Cambridge Biomedical Campus, coordinating commercial real estate activity and tenant relations.
• Campus Community Services Campus community services spanning social life, public art, work experience opportunities, and start-up support for staff, students, researchers, and visitors.
• Connector Autonomous Bus Trial Free autonomous bus trial service operating on the Cambridge Biomedical Campus, providing staff and visitors with a complimentary on-site transport option.
• Campus Travel Infrastructure Coordinated campus travel infrastructure including scheduled Stagecoach bus services, cycle lanes, and Park & Ride provisions for daily commuters, clinical and research staff, and visitors.

Quantifiable outcome

• £4.7 billion annual contribution to UK economy
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Edinburgh BioQuarter: Life sciences campus co-locating the University of Edinburgh, NHS Lothian (Royal Infirmary), and commercial tenants including pharma. Highly comparable as a UK site combining academic research, hospital care, and industry on a single location with similar co-location thesis.
• Oxford Science Park: Major UK science and technology park near the University of Oxford, hosting biotech and life sciences tenants. Comparable as a UK university-adjacent life sciences park with property leasing, lab space, and a mixed academic/industry tenant model.
• MaRS Discovery District: Toronto innovation district co-locating health sciences, research, and start-ups adjacent to major hospitals and the University of Toronto. Comparable as a multi-tenant life sciences and innovation campus with co-location of research, clinical, and commercial activity.
• White City Innovation District: Imperial College London's expanding research and innovation campus in West London. Comparable as a UK university-anchored innovation district combining academic research, industry tenants, and new transport infrastructure (White City tube).
• Stevenage Bioscience Catalyst: UK life sciences campus co-locating GSK, the Cell & Gene Therapy Catapult, and academic partners. Closely comparable as a UK-based life sciences research and incubation campus with major pharma anchor tenant and public-private governance model.
• Longwood Medical Area: Boston's premier medical and life sciences district hosting Harvard Medical School, Brigham and Women's, Beth Israel, and major biotech/pharma offices. Comparable as a mature, dense life sciences and hospital cluster with co-location of academia, hospitals, and industry.
• UCSF Mission Bay: San Francisco life sciences cluster anchored by UCSF hospital and research campus, with adjacent biotech/pharma tenants. Comparable as a major life sciences campus combining a top academic medical centre with industry tenants in a purpose-built cluster.

Regional players

• Babraham Research Campus: Life sciences and biotech research campus located a few miles south of Cambridge. Directly comparable as another Cambridge-area life sciences campus with academic affiliation (Babraham Institute) and start-up/tenant community, though smaller in scale than CBC.
• Biopolis: Singapore's flagship biomedical research hub hosting A*STAR research institutes, pharma, and biotech tenants. Comparable as a purpose-built, government-coordinated life sciences cluster combining public research bodies and industry tenants.

Broad incumbents

• Research Triangle Park: Large North Carolina research park hosting academic, government, and life sciences tenants. Comparable as a major multi-tenant research cluster, though broader in scope (not life-sciences-only) and operating under different governance.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cambridge-biomedical-campus

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAMBRIDGE BIOMEDICAL CAMPUS LTD